ATE254616T1 - Dihydrat eines purinderivates, medikamente die dieses als aktiven wirkstoff enthalten und zwischenprodukte zu dessen herstellung - Google Patents

Dihydrat eines purinderivates, medikamente die dieses als aktiven wirkstoff enthalten und zwischenprodukte zu dessen herstellung

Info

Publication number
ATE254616T1
ATE254616T1 AT00923000T AT00923000T ATE254616T1 AT E254616 T1 ATE254616 T1 AT E254616T1 AT 00923000 T AT00923000 T AT 00923000T AT 00923000 T AT00923000 T AT 00923000T AT E254616 T1 ATE254616 T1 AT E254616T1
Authority
AT
Austria
Prior art keywords
dihydrate
production
medications
contain
active ingredient
Prior art date
Application number
AT00923000T
Other languages
English (en)
Inventor
Kouichi Sekiya
Akihiro Takemiya
Masahiro Ohshima
Original Assignee
Mitsubishi Chem Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chem Corp filed Critical Mitsubishi Chem Corp
Application granted granted Critical
Publication of ATE254616T1 publication Critical patent/ATE254616T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/36—Sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT00923000T 1999-05-11 2000-05-09 Dihydrat eines purinderivates, medikamente die dieses als aktiven wirkstoff enthalten und zwischenprodukte zu dessen herstellung ATE254616T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12949999 1999-05-11
PCT/JP2000/002952 WO2000068231A1 (en) 1999-05-11 2000-05-09 Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof

Publications (1)

Publication Number Publication Date
ATE254616T1 true ATE254616T1 (de) 2003-12-15

Family

ID=15011000

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00923000T ATE254616T1 (de) 1999-05-11 2000-05-09 Dihydrat eines purinderivates, medikamente die dieses als aktiven wirkstoff enthalten und zwischenprodukte zu dessen herstellung

Country Status (12)

Country Link
US (2) US6660745B1 (de)
EP (1) EP1178046B1 (de)
JP (1) JP3956188B2 (de)
KR (1) KR100747106B1 (de)
CN (1) CN1160355C (de)
AT (1) ATE254616T1 (de)
AU (1) AU4319000A (de)
CA (1) CA2373015A1 (de)
DE (1) DE60006663T2 (de)
ES (1) ES2206227T3 (de)
TW (1) TW546298B (de)
WO (1) WO2000068231A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1130363C (zh) 1997-11-12 2003-12-10 三菱化学株式会社 嘌呤衍生物以及含有其作为有效成分的药物
WO2000068231A1 (en) 1999-05-11 2000-11-16 Mitsubishi Chemical Corporation Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof
US7772123B2 (en) * 2008-06-06 2010-08-10 Infineon Technologies Ag Through substrate via semiconductor components
JP2021035910A (ja) * 2017-11-01 2021-03-04 大日本住友製薬株式会社 置換プリン化合物

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3936454A (en) 1973-08-14 1976-02-03 Warner-Lambert Company 5-Amino-4-chloro-6-(substituted amino)-pyrimidines
US3862189A (en) 1973-08-14 1975-01-21 Warner Lambert Co Aralkyl-substituted purines and pyrimidines as antianginal bronchodilator agents
US4193926A (en) 1974-03-20 1980-03-18 Schering Aktiengesellschaft 4-(Polyalkoxy phenyl)-2-pyrrolidones
DE2413935A1 (de) 1974-03-20 1975-10-16 Schering Ag 4-(polyalkoxy-phenyl)-2-pyrrolidone
US5124455A (en) 1990-08-08 1992-06-23 American Home Products Corporation Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents
IE71647B1 (en) 1991-01-28 1997-02-26 Rhone Poulenc Rorer Ltd Benzamide derivatives
GB9210839D0 (en) 1992-05-21 1992-07-08 Smithkline Beecham Plc Novel compounds
IL107611A0 (en) 1992-11-18 1994-02-27 Smithkline Beecham Corp Steroid compounds and pharmaceutical compositions containing them
NZ257955A (en) 1992-12-02 1996-05-28 Pfizer Catechol diethers pharmaceutical compositions
TW263495B (de) 1992-12-23 1995-11-21 Celltech Ltd
GB9312853D0 (en) 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5380838A (en) 1993-10-08 1995-01-10 Merck & Co. Inc. Stable solvates of avermectin compounds
ATE186732T1 (de) 1994-01-07 1999-12-15 Merrell Pharma Inc (e)-2'-deoxy-2'-(fluormethylen)cytidin-monohydr t
GB9420503D0 (en) 1994-10-11 1994-11-23 Pfizer Ltd Therapeutic agents
CN1067998C (zh) * 1994-11-14 2001-07-04 第一制药株式会社 药用水合物
DE19501482A1 (de) 1995-01-19 1996-07-25 Bayer Ag 2,9-disubstituierte Purin-6-one
GB9503717D0 (en) 1995-02-24 1995-04-12 Smithkline Beecham Plc Novel compounds
US5580977A (en) 1995-03-01 1996-12-03 Eli Lilly And Company Process for preparing loracarbef monohydrate
SE9501808D0 (sv) 1995-05-16 1995-05-16 Astra Ab New process
US5948931A (en) 1996-07-12 1999-09-07 University Of Southern California Preparation and use of α-(hydroxyimino) phosphonoacetic acids
CN1130363C (zh) 1997-11-12 2003-12-10 三菱化学株式会社 嘌呤衍生物以及含有其作为有效成分的药物
WO2000068231A1 (en) 1999-05-11 2000-11-16 Mitsubishi Chemical Corporation Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof

Also Published As

Publication number Publication date
CN1160355C (zh) 2004-08-04
DE60006663D1 (de) 2003-12-24
CA2373015A1 (en) 2000-11-16
EP1178046B1 (de) 2003-11-19
US6919455B2 (en) 2005-07-19
US6660745B1 (en) 2003-12-09
US20040077665A1 (en) 2004-04-22
EP1178046A4 (de) 2002-06-05
ES2206227T3 (es) 2004-05-16
EP1178046A1 (de) 2002-02-06
AU4319000A (en) 2000-11-21
KR20020015039A (ko) 2002-02-27
WO2000068231A1 (en) 2000-11-16
TW546298B (en) 2003-08-11
JP3956188B2 (ja) 2007-08-08
KR100747106B1 (ko) 2007-08-08
CN1350535A (zh) 2002-05-22
DE60006663T2 (de) 2004-10-07

Similar Documents

Publication Publication Date Title
IT1254317B (it) Perfezionato impiego di medicinali broncodilatatori b2.
UA85708C2 (ru) Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей
WO2002085909A8 (en) 9-deazaguanine derivatives as inhibitors of gsk-3
BRPI0409427A (pt) composto, uso do mesmo, composição farmacêutica, método de tratamento de um humano sofrendo de uma doença hiperproliferativa, e, processo para a preparação de um composto ou de um sal, éster ou pró-droga farmaceuticamente aceitáveis do mesmo
WO1997020823A3 (en) 2-amino quinazoline derivatives as npy receptor antagonists
SE9701398D0 (sv) Novel compounds
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
WO2004026863A8 (en) Novel oxazole and thiazole compounds as transforming growth factor (tgf) inhibitors
MXPA03010810A (es) Pirimidinas inhibidoras de cdk, su obtencion y su uso como medicamentos.
WO2006034446A3 (en) Pyridine derivatives for inhibiting human stearoyl-coa-desaturase
DE60317562D1 (de) Benzofuranderivate,verfahren zu deren herstellung und zwischenprodukte davon
BRPI0408727A (pt) composto, processo para preparar o mesmo, composição farmacêutica, método para tratar de uma condição ou estado de doença mediados pela atividade da quinase p38 ou mediados pelas citocinas produzidas pela atividade da quinase p38, e, uso de um composto
MXPA04005156A (es) Antagonistas del receptor de adenosina a2a.
MXPA04002825A (es) Derivados de quinolina como antagonistas de neuropeptido y.
EP1477489A4 (de) Pyrrolopyrimidinderivate
WO2007071963A3 (en) Quinazoline derivatives, process for their preparation and their use as anti-cancer agents
MXPA05011207A (es) Uso de derivados de 2,4-dihidro-[1,2,4]triazol-3-tiona como inhibidores de la enzima mieloperoxidasa (mpo).
WO2005014572A8 (en) Pyrimidylpyrrole derivatives active as kinase inhibitors
WO2003087049A3 (de) Arzneimittelkombinationen enthaltend heterocyclische verbindungen und ein neues anticholinergikum
WO2005115470A3 (fr) COMPOSITIONS PHARMACEUTIQUES CONTENANT DES DERIVES DE β-­CARBOLINE, ET LEUR UTILISATION POUR LE TRAITEMENT DES CANCERS
NO20071321L (no) Anti-inflammatoriske midler
WO2003028715A3 (en) Methods using 1, 2-dithiol-3-thiones and their derivatives and metabolites for inhibiting angiogenesis
WO2002087596A3 (en) Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases
BR0307588A (pt) Composto, inibidor de gsk-3, composição farmacêutica, e, agente terapêutico ou preventivo para uma doença
WO2003031447A3 (de) Pyrimidinderivate mit pde-v hemmender wirkung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties